Search results

Page results

• Single-dose radiotherapy as effective for treating breast cancer, long-term study finds

  A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.

• Infectious disease update during COVID-19

  All GPs are now welcome to use our national Infectious & Tropical Disease Advice and Guidance function on the e-referral system (NHS e-RS)

• SUMMIT Study catches up with pre-pandemic follow up appointments

  As World Lung Cancer Day approaches (1 August) the SUMMIT Study reports that it has made great strides in catching up with patients whose nodule follow ups were cancelled due to COVID-19.

• UCLH to be part of vital health data partnership

  UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.

• Patient Advice and Liaison Service (PALS)

  Patient Advice and Liaison Service (PALS)

• Series No 5 - Molecular Radiotherapy for adults having radioactive iodine (131I) treatment

  This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.

• Jaydam Tierney - occupational therapist

  Jaydam Tierney had wanted to be an occupational therapist since school, and is now enjoying the fast-paced environment of the emergency department.

• What is acute myeloid leukaemia (AML)?

  Acute Myeloid Leukaemia (AML) is a form of cancer that develops in your bone marrow and affects your blood cells.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.

• Stroke nurses first in the UK to implant cardiac monitors in patients

  The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.